The South and Central America pain management devices market is expected to reach US$ 477.32 million by 2027 from US$ 276.75 million in 2019. The market is estimated to grow with a CAGR of 7.1 % from 2020 to 2027.
The South and Central America pain management devices market is expected to grow due to rising incidence of chronic pain and initiatives by market players during the forecast period. However, the high cost of these devices restricts the market growth among the middle-income countries.
Cancer, cardiovascular diseases, neurovascular diseases, and musculoskeletal diseases are known to generate excruciating pain in affected individuals, with adults and elderly being the most vulnerable groups. According to the Centers for Disease Control and Prevention (CDC) data as of September 2017, the prevalence of chronic pain was 39% among the Brazilians—average age was 41 years with predominance of female (56%). The data also showed that the prevalence of chronic pain in southern and southeastern regions was comparatively higher, i.e., 43% and 40%, respectively. Nevertheless, the prevalence of the aforementioned disease is now being significantly noticed in children leading to episodes of chronic pain. Also, athletes, sportspersons, and people with a history of past injuries have reported to experience events of chronic pain.
A person suffering from chronic pain would require assistance in performing various daily tasks; therefore, pain management becomes essential for such individuals. Pain management devices provide relief for longer durations and also improve health. A wearable pain management device is easy to use and operate, thereby making the wearer self-reliant.
South and Central America Pain Management Devices Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
South and Central America Pain Management Devices Market – Market Segmentation
By Product
- Neuromodulation Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Spinal Cord Stimulation (SCS) Devices
- Ablation Devices
- Radiofrequency Ablation Devices
- Cryoablation Devices
- Analgesic Infusion Pumps
- Intrathecal Infusion Pumps
- External Infusion Pumps
By Application
- Neuropathic Pain
- Cancer Pain
- Facial Pain and Migraine
- Musculoskeletal Pain
- Others
By Country
- Brazil
- Argentina
Company Profiles
- Pfizer Inc
- Abbott
- Boston Scientific Corporation
- Medtronic
- BD
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SCAM Pain Management Devices Market – By Product
1.3.2 SCAM Pain Management Devices Market– By Application
1.3.3 SCAM Pain Management Devices Market – By Country
2. SCAM Pain Management Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SCAM Pain Management Devices Market Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 PEST Analysis
4.3.1 North America– PEST Analysis
4.4 Expert Opinion
5. SCAM Pain Management Devices Market Key Market Dynamics
5.1 Key Market Drivers
5.2 Market Drivers
5.2.1 Growing Incidences of Chronic Pain
5.2.2 Market Player Initiatives
5.3 Market Restraints
5.3.1 High Cost of Pain Management Devices
5.4 Opportunities
5.4.1 Growth Demand for Neurostimulation Devices
5.5 Trends
5.5.1 Technological Advancement
5.6 Impact Analysis
6. Pain Management Devices Market – SCAM Analysis
6.1 SCAM Pain Management Devices Market Revenue Forecasts and Analysis
7. Pain Management Devices Market Analysis – By Product Type
7.1 Overview
7.2 Pain Management Devices Market Share, by Product Type, 2019 and 2027 (%)
7.3 Neuromodulation Devices
7.3.1 Overview
7.3.2 Neuromodulation Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.3.3 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.3.3.1 Overview
7.3.3.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.3.4 Spinal Cord Stimulation (SCS) Devices
7.3.4.1 Overview
7.3.4.2 Spinal Cord Stimulation (SCS) Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Ablation Devices
7.4.1 Overview
7.4.2 Ablation Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Radiofrequency Ablation Devices
7.4.3.1 Overview
7.4.3.2 Radiofrequency Ablation Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Cryoablation Devices
7.4.4.1 Overview
7.4.4.2 Cryoablation Devices: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesic Infusion Pumps
7.5.1 Overview
7.5.2 Analgesic Infusion Pumps: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.5.3 Intrathecal Infusion Pumps
7.5.3.1 Overview
7.5.3.2 Intrathecal Infusion Pumps: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
7.5.4 External Infusion Pumps
7.5.4.1 Overview
7.5.4.2 External Infusion Pumps: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
8. Pain Management Devices Market Analysis – By Application
8.1 Overview
8.2 Pain Management Devices Market Share, by Application, 2019 and 2027 (%)
8.3 Neuropathic Pain
8.3.1 Overview
8.3.2 Neuropathic Pain: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
8.4 Facial Pain and Migraine
8.4.1 Overview
8.4.2 Facial Pain and Migraine: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
8.5 Musculoskeletal Pain
8.5.1 Overview
8.5.2 Musculoskeletal Pain: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
8.6 Cancer Pain
8.6.1 Overview
8.6.2 Cancer Pain: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Pain Management Devices Market– Revenue and Forecast to 2027 (US$ Million)
9. Pain Management Devices Market – Geographic Analysis
9.1 North America: Pain Management Devices Market
9.1.1 Overview
9.1.2 North America: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Pain Management Devices Market, by Product Type, 2018–2027 (USD Million)
9.1.3.1 North America: Neuromodulation Devices, Market, by Type, 2018–2027 (USD Million)
9.1.3.2 North America: Ablation Devices Market, by Type, 2018–2027 (USD Million)
9.1.3.3 North America: Analgesic Infusion Pumps Market, by Type, 2018–2027 (USD Million)
9.1.4 North America: Pain Management Devices Market, by Application, 2018–2027 (USD Million)
9.1.5 North America: Pain Management Devices Market, by Country, 2019 & 2027 (%)
9.1.5.1 US: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US: Pain Management Devices Market, by Product Type, 2018–2027 (USD Million)
9.1.5.1.2.1 US: Neuromodulation Devices, Market, by Type, 2018–2027 (USD Million)
9.1.5.1.2.2 US: Ablation Devices Market, by Type, 2018–2027 (USD Million)
9.1.5.1.2.3 US: Analgesic Infusion Pumps Market, by Type, 2018–2027 (USD Million)
9.1.5.1.3 US: Pain Management Devices Market, by Application, 2018–2027 (USD Million)
9.1.5.2 Canada: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada: Pain Management Devices Market, by Product Type, 2018–2027 (USD Million)
9.1.5.2.2.1 Canada: Neuromodulation Devices, Market, by Type, 2018–2027 (USD Million)
9.1.5.2.2.2 Canada: Ablation Devices Market, by Type, 2018–2027 (USD Million)
9.1.5.2.2.3 Canada: Analgesic Infusion Pumps Market, by Type, 2018–2027 (USD Million)
9.1.5.2.3 Canada: Pain Management Devices Market, by Application, 2018–2027 (USD Million)
9.1.5.3 Mexico: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico: Pain Management Devices Market, by Product Type, 2018–2027 (USD Million)
9.1.5.3.2.1 Mexico: Neuromodulation Devices, Market, by Type, 2018–2027 (USD Million)
9.1.5.3.2.2 Mexico: Ablation Devices Market, by Type, 2018–2027 (USD Million)
9.1.5.3.2.3 Mexico: Analgesic Infusion Pumps Market, by Type, 2018–2027 (USD Million)
9.1.5.3.3 Mexico: Pain Management Devices Market, by Application, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on SCAM Pain Management Devices Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 BD
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Medtronic
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Abbott
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. SCAM Pain Management Devices Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 2. SCAM Pain Management Devices Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. SCAM Pain Management Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. US Pain Management Devices Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. US Pain Management Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Pain Management Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Pain Management Devices Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Pain Management Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Pain Management Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Pain Management Devices Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Pain Management Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Pain Management Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 1. Glossary of Terms, SCAM Pain Management Devices Market
LIST OF FIGURES
Figure 1. Pain Management Devices Market Segmentation
Figure 2. SCAM Pain Management Devices Market Overview
Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pain Management Devices Market
Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. SCAM Pain Management Devices Market- Leading Country Markets (US$ Mn)
Figure 7. SCAM Pain Management Devices Market - SCAM PEST Analysis
Figure 8. Pain Management Devices Market Impact Analysis of Drivers and Restraints
Figure 9. SCAM Pain Management Devices Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. SCAM Pain Management Devices Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 11. Oral Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Injectable Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Topical Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Ocular Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Pulmonary Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Nasal Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Transmucosal Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Implantable Drug Delivery: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. SCAM Pain Management Devices Market Revenue Share, by Application (2019 and 2027)
Figure 20. Infectious Diseases: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cancer: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cardiovascular Diseases: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Diabetes: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Respiratory Diseases: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Central Nervous Systems Disorders: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Autoimmune Diseases: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Other Diseases: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. SCAM Pain Management Devices Market Share, by End User, 2019 and 2027 (%)
Figure 29. Hospitals: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Home Care Settings: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. ASCs/ Clinics: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Other End Users: Pain Management Devices Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Pain Management Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. SCAM Pain Management Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Pain Management Devices Market, by Country, 2019 & 2027 (%)
Figure 36. US: Pain Management Devices market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Pain Management Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets
- Pfizer Inc
- Abbott
- Boston Scientific Corporation
- Medtronic
- BD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to South & Central America Pain Management Devices Market
Nov 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)